Medicine for treating spleen and stomach
Through modern technology extraction and enzymatic anti-medicine materials, combined with probiotics and nano-wrap technology, the existing spleen and stomach regulation drug loss and low bioavailability have been solved, gastrointestinal mucosa repair and bacterial flora regulation have been achieved, and the efficacy and maintenance time have been improved.
Patent Information
- Application Number
- CN202510781730.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-06-12
- Publication Date
- 2025-07-25
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing spleen and stomach conditioning drugs have loss of active ingredient, low bioavailability, failure to effectively integrate mucosal repair and bacterial flora regulation, neglect the digestive burden brought by changes in modern dietary structure, and lack of a precise active ingredient delivery system, resulting in slow effect and short maintenance time.
The medicinal materials such as Atractylodes macrocephala, Polygonatum, Monkey cephala, Perilla stem, Chicken gizzard, Puerarin are used to extract and enzymatically dissolve through modern technology, combined with probiotics and nano-wrap technology, a multi-dimensional repair mechanism is formed to achieve gastrointestinal mucosa repair and bacterial flora regulation, and targeted repair of damaged tissue.
It improves the bioavailability of drugs, enhances the segmented targeting effect of gastrointestinal tract, improves the gastrointestinal microecology environment, relieves common gastrointestinal discomfort symptoms in modern people, and achieves the care goal of short-term symptom relief and long-term physical fitness improvement.
Smart Images

Figure CN120361159A_ABST
